Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.36
+0.02 (0.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Abeona Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
3052862421245349
Upgrade
Market Cap Growth
36.54%17.95%95.09%134.61%7.07%-68.06%
Upgrade
Enterprise Value
1381031567643-11
Upgrade
Last Close Price
5.365.275.575.013.088.43
Upgrade
PE Ratio
5.284.01----
Upgrade
PS Ratio
52.3949.07-35.4637.4116.47
Upgrade
PB Ratio
1.851.795.508.371.981.17
Upgrade
P/TBV Ratio
1.911.795.508.371.981.21
Upgrade
EV/Sales Ratio
23.7917.63-21.7330.43-
Upgrade
Debt / Equity Ratio
0.160.160.520.360.280.22
Upgrade
Net Debt / Equity Ratio
-1.04-1.04-1.70-3.16-1.66-0.84
Upgrade
Net Debt / EBITDA Ratio
1.921.921.201.021.060.66
Upgrade
Net Debt / FCF Ratio
1.971.971.281.251.020.51
Upgrade
Asset Turnover
0.040.04-0.060.020.03
Upgrade
Quick Ratio
6.706.705.994.076.732.89
Upgrade
Current Ratio
6.936.936.084.156.833.39
Upgrade
Return on Equity (ROE)
70.05%70.05%-216.57%-260.60%-114.85%-117.22%
Upgrade
Return on Assets (ROA)
-34.04%-34.04%-46.41%-46.99%-39.34%-31.07%
Upgrade
Return on Invested Capital (ROIC)
------499.52%
Upgrade
Return on Capital Employed (ROCE)
-47.10%-47.10%-69.50%-95.30%-80.20%-91.10%
Upgrade
Earnings Yield
23.35%24.93%-26.32%-43.66%-75.04%-171.90%
Upgrade
FCF Yield
-27.65%-29.52%-24.14%-30.09%-82.44%-141.30%
Upgrade
Buyback Yield / Dilution
-61.12%-61.12%-91.99%-171.96%-99.65%-6.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.